by MSD
by Janssen with support from Learning Solutions from Syneos Health
by AstraZeneca with support from CMC
by Mundipharma with support from Uptake Strategies Ltd
by Takeda UK Ltd with support from Interaction Marketing & PR
by Janssen with support from Learning Solutions from Syneos Health
The planet is currently experiencing global healthcare crises that affect huge populations. From diabetes to Alzheimer’s to mental health conditions, we still lack the research and real-world data (RWD) to fully progress into an era of personalised medicine. At the same time, underserved populations with rare diseases struggle to receive treatment and real-world evidence (RWE) about living and thriving with their conditions.
Regardless of the disease area or treatment option, RWD that is effectively planned for, collected and analysed outside of traditional clinical trial settings, is emerging as integral to the future of global health.
Janssen’s strategy was to create standardised content and delivery mechanisms that resulted in customised experiences for the large and diverse audience of over 5,000 employees.
Communities are more connected and opportunities have increased in abundance within the business to enable visibility of RWE content that drives less duplication of data and usage of data assets through the metrics.
This excellent programme by Janssen and Syneos Health had an exceptional strategy built on real insights and executed to a high standard. It was very well run and addressed a specific skill need, filling a capability gap.
Entry deadline | 26 August 2022 |
Extended entry deadline | 2 September 2022* *additional fee applies |
Judging Day | 6 October 2022 |
Company/Team of the Year Interviews | 21 October 2022 |
PMEA Event | 23 November 2022 |